LENTRIS 4MG CAPSULE
Form: Capsules
Pack Size: 10 CAPSULES
Marketed by: MYLAN PHARMACEUTICALS PVT LTD (ONCOLOGY DIV)
MRP: ₹868.21
MYLAN PHARMACEUTICALS PVT LTD (ONCOLOGY DIV): Lentris 4MG Capsule, 10 capsules, salt lenvatinib 4mg. NPPA has revised its MRP from Rs 1,640 to Rs 868.21 (47% lower) with effect from 09-11-2026; trade rate Rs 661.49. Group: multi-kinase inhibitor (targeted therapy). Same salt is also supplied by BPRL, Cipla, Eisai, Glenmark, Hetero and others. Handling/counselling: capsules can be dispersed in water or juice if the patient cannot swallow. Schedule H - supply only to licensed buyers and dispense only on prescription.
Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.